Our investor information pages are under reconstruction. New pages will be published soon.

Contact for investors:

CEO
Stein Ulve
Tel. +358 400 22 5967

stein.ulve@eeviahealth.com

——————————————————–

Please find here the Exemption document

Investment teaser you can download here

———————————————————

PRESS RELEASES

Notice Rights Issue 17 01 2025

Communique EGM January 17 01 2025

Notice to the Extraordinary General Meeting 17 01 2025

Interim Report Q3 – 2024

Notice to the EGM 04 11 2024

Interim Report Q2 – 2024

Correction: Eevia publishes the outcome of the rights issue 11 07 2024

Communique from the AGM 28 06 2024

Restated Interim report Q1 – 2024

Notice of the AGM 28 06 2024